Impact of vitamin K dosing during sorafenib treatment for hepatocellular carcinoma: Effect on ischemic tumor cell damage caused by sorafenib.

被引：0
|
作者：
Haruna, Yoshimichi
Hasegawa, Noriko
Imanaka, Kazuho
Inoue, Atsuo
Kudo, Masatoshi
机构：
[1] Osaka Gen Med Ctr, Osaka, Japan
[2] Kinki Univ, Sch Med, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e15585
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15585
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical Impact of Vitamin K Dosing on Sorafenib Treatment for Hepatocellular Carcinoma
    Haruna, Yoshimichi
    Hasegawa, Noriko
    Imanaka, Kazuho
    Kawamoto, Seiichi
    Inoue, Atsuo
    JOURNAL OF CANCER, 2017, 8 (11): : 1988 - 1994
  • [2] Vitamin K dosing during sorafenib treatment for hepatocellular carcinoma markedly prolonged overall survival as well as progression free survival probably by augmented ischemic tumor cell damage
    Haruna, Yoshimichi
    Inoue, Atsuo
    HEPATOLOGY, 2015, 62 : 297A - 297A
  • [3] Impact of HCV treatment in patients with advanced hepatocellular carcinoma on sorafenib.
    Herman, Michael
    Zhang, Yuhua
    Wang, Lisa
    Sim, Hao-Wen
    Knox, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Vitamin K dosing could improve anticancer outcome of sorafenib treatment for hepatocellular carcinoma
    Haruna, Yoshimichi
    Inoue, Atsuo
    HEPATOLOGY, 2013, 58 : 1237A - 1238A
  • [5] Synergistic Effect of Sorafenib and Vitamin K on Suppression of Hepatocellular Carcinoma Cell Migration and Metastasis
    Ha, Tae-Yong
    Hwang, Shin
    Hong, Hea-Nam
    Choi, Young-Il
    Yoon, Sam-Youl
    Won, You-Jin
    Song, Gi-Won
    Kim, Nayoung
    Tak, Eunyoung
    Ryoo, Baek-Yeol
    ANTICANCER RESEARCH, 2015, 35 (04) : 1985 - 1995
  • [6] Symptomatic brain metastases from renal cell carcinoma during treatment with sunitinib or sorafenib.
    Larkin, J. M.
    Hess, V.
    Pickering, L. M.
    Ferguson, T.
    Forrest, R.
    Gore, M. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Effect of specialized nursing intervention on the prognosis of hepatocellular carcinoma patients treated with sorafenib.
    Pang, Xufeng
    Li, Guizhi
    Lv, Yaqing
    Wang, Juanjuan
    Wei, Lili
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (02): : 791 - 796
  • [8] Portal Vein Tumor Thrombosis Revascularization During Sorafenib Treatment for Hepatocellular Carcinoma
    Novi, Marialuisa
    Lauritano, Ernesto C.
    Piscaglia, Anna C.
    Barbaro, Brunella
    Zocco, Maria A.
    Pompili, Maurizio
    Gasbarrini, Antonio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (07): : 1852 - 1854
  • [9] Intracranial Bleeding during Treatment with Sorafenib for Hepatocellular Carcinoma
    Hata, Taigo
    Uwagawa, Tadashi
    Yanaga, Katsuhiko
    LIVER CANCER, 2019, 8 (06) : 520 - 521
  • [10] Tumor lysis syndrome after treatment with sorafenib for hepatocellular carcinoma
    Kudo, Chieko
    Miura, Masahito
    Gamoh, Makio
    Niitani, Tomohito
    Tamagawa, Hiroki
    Takahashi, Kiichi
    Ichikawa, Sonoko
    Sugiyama, Katsuo
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2015, 4 (03): : 147 - 150
12345